<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02582450</url>
  </required_header>
  <id_info>
    <org_study_id>Veritas-Validation</org_study_id>
    <nct_id>NCT02582450</nct_id>
  </id_info>
  <brief_title>Validation of a Specific Measure for Assessment of Compliance With Treatment in Patients With Hemophilia</brief_title>
  <official_title>Validation of a Specific Measure for Assessment of Compliance With Treatment in Patients With Hemophilia. Veritas-Pro Project</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Real Fundación Victoria Eugenia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtep Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Real Fundación Victoria Eugenia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Research project for validation of a questionnaire on compliance to treatment in patients
      with hemophilia. It is intended to validate the American VERITAS-PRO scale according to the
      international methodology validation questionnaires: reverse translation, according to
      intersubject patients, psychometric validation and reliability analysis with large sample of
      patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The validated questionnaire obtained in this project will identify the actual degree of
      patient compliance to drug therapy, using as gold standard the difference between the
      treatment prescribed and administered.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">October 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Translation of the original questionnaire (English) to Spanish</measure>
    <time_frame>1 day (Screening visit)</time_frame>
    <description>Three health experienced in the treatment of hemophilia and knowledge of English, translated into Spanish the HAL and HEP questionnaire. Two native speakers (English and Spanish), reverse-translate the original text of the HAL and HEP questionnaires and the text translated by the Spanish health.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The translated version of the questionnaire</measure>
    <time_frame>1 day (Screening visit)</time_frame>
    <description>10 patients with hemophilia adults enrolled randomly will participate in the pilotage.
The clarity of the questions in Spanish translated version and the relevance of each of the items of the questionnaires will be evaluated.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sending the questionnaire to a large sample of patients for final validation</measure>
    <time_frame>1 day (Screening visit)</time_frame>
    <description>70 patients with hemophilia will participate in the pilotage. The validity and reliability of the Spanish version translated from the questionnaires will be assessed.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Haemophilia</condition>
  <arm_group>
    <arm_group_label>Patients with haemophilia</arm_group_label>
    <description>Sample of patients with haemophilia over 18 years of age that will participate in piloting of reliability and validity of the Spanish version of the Veritas-Pro questionnaire.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Patients with haemophilia</intervention_name>
    <description>Piloting of reliability and validity of the Spanish version of the Veritas-Pro questionnaire.</description>
    <arm_group_label>Patients with haemophilia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with haemophilia around the country that will participate in study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with hemophilia A and B

          -  Patients who have previously signed the informed consent document

        Exclusion Criteria:

          -  Patients with other congenital coaghulopatías (eg, Von Willebrand's disease)

          -  Patients with cognitive impairment, or oral or written understanding
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rubén Cuesta-Barriuso, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Real Fundación Victoria Eugenia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rubén Cuesta-Barriuso, PhD</last_name>
    <phone>+34 913146508</phone>
    <email>ruben.cuestab@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ana Torres-Ortuño, PhD</last_name>
    <phone>+34 868887170</phone>
    <email>atorres.ortuno@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Real Fundación Victoria Eugenia</name>
      <address>
        <city>Madrid</city>
        <zip>28029</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rubén Cuesta-Barriuso, PhD</last_name>
      <phone>+34 913146508</phone>
      <email>ruben.cuestab@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 19, 2015</study_first_submitted>
  <study_first_submitted_qc>October 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2015</study_first_posted>
  <last_update_submitted>October 19, 2015</last_update_submitted>
  <last_update_submitted_qc>October 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Haemophilia</keyword>
  <keyword>Adherence of Treatment</keyword>
  <keyword>Knowledge of Illness</keyword>
  <keyword>Medical-patient Relationship</keyword>
  <keyword>Illness Behavior</keyword>
  <keyword>Treatment Difficulties</keyword>
  <keyword>Veritas</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemophilia A</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>June 29, 2016</submitted>
    <returned>August 12, 2016</returned>
    <submitted>August 26, 2016</submitted>
    <returned>October 18, 2016</returned>
    <submitted>December 30, 2016</submitted>
    <returned>February 21, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

